We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

93 hedge funds and large institutions have $19.5M invested in Zomedica Corp. in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

2% more funds holding

Funds holding: 91 → 93 (+2)

5% less capital invested

Capital invested by funds: $20.5M → $19.5M (-$997K)

13% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 15

Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
15
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$257K
2
ProShare Advisors
ProShare Advisors
Maryland
+$166K
3
TSS
Two Sigma Securities
New York
+$66.2K
4
Squarepoint
Squarepoint
New York
+$64.8K
5
XT
XTX Topco
Cayman Islands
+$41.7K

Top Sellers

Rank Fund Capital Flow
1
PWMG
Pinnacle Wealth Management Group
Michigan
-$206K
2
Jane Street
Jane Street
New York
-$140K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$48.7K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$36.4K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$29.3K

ZOM Hedge Fund Activity: Q2 2023 in Review

93 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2023, worth a combined $19.5M — down 4.9% from $20.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ZOM positions and 8 closed out — a net gain of 2 holders — while 13 added to existing stakes and 15 trimmed.

The largest buyer was BlackRock, adding an estimated $257K. The largest seller was Pinnacle Wealth Management Group, exiting entirely with an estimated $206K sold.

  • 93 institutional investors held Zomedica Corp. (ZOM) as of Q2 2023, up from 91 in Q1 2023.
  • Funds reported $19.5M of Zomedica Corp. stock for Q2 2023, down 4.9% quarter-over-quarter.
  • 10 funds opened new Zomedica Corp. positions in Q2 2023 and 8 closed out, a net change of +2 holders.
  • The largest Zomedica Corp. buyer in Q2 2023 was BlackRock, an estimated $257K added.
  • The largest Zomedica Corp. seller in Q2 2023 was Pinnacle Wealth Management Group, an estimated $206K sold.

Based on aggregated 13F filings for Q2 2023.